ResMed Inc annual revenue for fiscal TTM was $5.5 billion, an increase of 7.6% from $5.1 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Revenue (annual) | TTM → 2026-03-31 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2010-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 | 2006-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $5.5B | $5.1B | $4.7B | $4.2B | $3.6B | $3.2B | $3.0B | $2.6B | $2.3B | $2.1B | $1.8B | $1.7B | $1.6B | $1.5B | $1.4B | $1.2B | $1.1B | $921M | $835M | $716M | $607M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Revenue (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.4B | $1.4B | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | $1.2B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RMD metrics: Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All RMD financial statements → Interactive RMD charts →
About TickerBase · Data methodology & sources